123 related articles for article (PubMed ID: 27422441)
1. MAGEA3 methylation status is associated with prognosis of malignant peripheral nerve sheath tumor and with neurofibroma type in neurofibromatosis type 1.
Nobeyama Y; Nakagawa H
J Dermatol Sci; 2016 Oct; 84(1):101-104. PubMed ID: 27422441
[No Abstract] [Full Text] [Related]
2. Aberrant demethylation and expression of MAGEB2 in a subset of malignant peripheral nerve sheath tumors from neurofibromatosis type 1.
Nobeyama Y; Nakagawa H
J Dermatol Sci; 2016 Feb; 81(2):118-23. PubMed ID: 26642794
[TBL] [Abstract][Full Text] [Related]
3. Expression of cathepsin K in neurofibromatosis 1-associated cutaneous malignant peripheral nerve sheath tumors and neurofibromas.
Yan X; Takahara M; Dugu L; Xie L; Gondo C; Endo M; Oda Y; Nakahara T; Uchi H; Takeuchi S; Tu Y; Moroi Y; Furue M
J Dermatol Sci; 2010 Jun; 58(3):227-9. PubMed ID: 20452751
[No Abstract] [Full Text] [Related]
4. SOX9 expression increases with malignant potential in tumors from patients with neurofibromatosis 1 and is not correlated to desert hedgehog.
Carbonnelle-Puscian A; Vidal V; Laurendeau I; Valeyrie-Allanore L; Vidaud D; Bièche I; Leroy K; Lantieri L; Wolkenstein P; Schedl A; Ortonne N
Hum Pathol; 2011 Mar; 42(3):434-43. PubMed ID: 21193222
[TBL] [Abstract][Full Text] [Related]
5. Malignant peripheral nerve sheath tumor of intracranial nerve: a case series review.
Ziadi A; Saliba I
Auris Nasus Larynx; 2010 Oct; 37(5):539-45. PubMed ID: 20399579
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical analysis of epigenetic factors to differentiate malignant peripheral nerve sheath tumor from benign neurofibroma in a patient with mosaic neurofibromatosis type 1: H3 lysine 27 trimethylation stain and enhancer of zeste homolog 2 stain.
Fukumoto T; Sakaguchi M; Oka M
J Dermatol; 2018 Nov; 45(11):e322-e324. PubMed ID: 29687471
[No Abstract] [Full Text] [Related]
7. Diagnostic and prognostic value of CD10 in peripheral nerve sheath tumors.
Cabibi D; Zerilli M; Caradonna G; Schillaci L; Belmonte B; Rodolico V
Anticancer Res; 2009 Aug; 29(8):3149-55. PubMed ID: 19661328
[TBL] [Abstract][Full Text] [Related]
8. Peripheral nerve sheath tumors arising in salivary glands: A clinicopathologic study.
Guraya SS; Prayson RA
Ann Diagn Pathol; 2016 Aug; 23():38-42. PubMed ID: 27402223
[TBL] [Abstract][Full Text] [Related]
9. Fibrolamellar nerve sheath tumor or sclerotic neurofibroma?
Goo B; Cho SB; Cho YH; Lee EH; Bang D; Kim YC; Vandersteen DP
J Cutan Pathol; 2006 Nov; 33(11):760-1. PubMed ID: 17083698
[No Abstract] [Full Text] [Related]
10. Giant malignant nerve sheath tumor of lumbosacral plexus with intraspinal extension in a child with neurofibromatosis type 1.
Pratap A; Nepal P; Agrawal A; Singh MP; Pandey SR
Pediatr Neurosurg; 2007; 43(5):410-3. PubMed ID: 17786009
[TBL] [Abstract][Full Text] [Related]
11. MRI features in the differentiation of malignant peripheral nerve sheath tumors and neurofibromas.
Wasa J; Nishida Y; Tsukushi S; Shido Y; Sugiura H; Nakashima H; Ishiguro N
AJR Am J Roentgenol; 2010 Jun; 194(6):1568-74. PubMed ID: 20489098
[TBL] [Abstract][Full Text] [Related]
12. Cross-sectional imaging of peripheral nerve sheath tumors: characteristic signs on CT, MR imaging, and sonography.
Lin J; Martel W
AJR Am J Roentgenol; 2001 Jan; 176(1):75-82. PubMed ID: 11133542
[No Abstract] [Full Text] [Related]
13. Routine use of immunohisto-chemistry may increase the frequency of hybrid peripheral nerve sheath tumors.
Pusiol T; Zorzi MG; Morichetti D; Piscioli F
Am J Dermatopathol; 2011 Aug; 33(6):634-6. PubMed ID: 21712692
[No Abstract] [Full Text] [Related]
14. Pilomatrixoma of the Neck/Shoulder Region Mimicking a Rapidly Growing Neoplasm of Peripheral Nerve Sheath Origin in Neurofibromatosis Type 1.
Friedrich RE; Schüller U; Hagel C
Anticancer Res; 2017 Dec; 37(12):6907-6910. PubMed ID: 29187472
[TBL] [Abstract][Full Text] [Related]
15. Methylation analysis of the neurofibromatosis type 1 (NF1) promoter in peripheral nerve sheath tumours.
Harder A; Rosche M; Reuss DE; Holtkamp N; Uhlmann K; Friedrich R; Mautner VF; von Deimling A
Eur J Cancer; 2004 Dec; 40(18):2820-8. PubMed ID: 15571966
[TBL] [Abstract][Full Text] [Related]
16. Differentially expressed genes in neurofibromatosis 1-associated neurofibromas and malignant peripheral nerve sheath tumors.
Holtkamp N; Mautner VF; Friedrich RE; Harder A; Hartmann C; Theallier-Janko A; Hoffmann KT; von Deimling A
Acta Neuropathol; 2004 Feb; 107(2):159-68. PubMed ID: 14673600
[TBL] [Abstract][Full Text] [Related]
17. Gene signature associated with benign neurofibroma transformation to malignant peripheral nerve sheath tumors.
Martínez M; Sorzano COS; Pascual-Montano A; Carazo JM
PLoS One; 2017; 12(5):e0178316. PubMed ID: 28542306
[TBL] [Abstract][Full Text] [Related]
18. Microscopic intraneural perineurial cell proliferations in patients with neurofibromatosis type 1.
Agaimy A
Ann Diagn Pathol; 2014 Apr; 18(2):95-8. PubMed ID: 24461704
[TBL] [Abstract][Full Text] [Related]
19. [Malignant peripheral nerve sheath tumor in the parotid gland developed on the basis of neurofibromatosis type 1].
Başaran B; Orhan KS; Polat B; Mete O; Başerer N
Kulak Burun Bogaz Ihtis Derg; 2011; 21(4):220-4. PubMed ID: 21762053
[TBL] [Abstract][Full Text] [Related]
20. Malignant peripheral nerve sheath tumor in neurofibromatosis type 1.
Rossiter JP; Fenton PV
JAMA Neurol; 2014 Feb; 71(2):242. PubMed ID: 24343189
[No Abstract] [Full Text] [Related]
[Next] [New Search]
